Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Allergen Challenge with Dissolved Itulazax
NCT06085963Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of SQ SLIT-tablet in Birch Pollen Allergic Rhinitis (BPAR) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Total Nasal Symptom Score at 30 minutes and Peak Nasal Inspiratory Flow at 30 minutes. Started Feb 2023; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
Birch Pollen Allergic Rhinitis (BPAR)
Beyond the preview
Go deeper on NCT06085963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085963.